Stay updated on Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page
- Check4 days agoChange DetectedVersion label on the page updated from v3.5.4 to v3.5.5, indicating a new page revision. The change does not alter the study details or eligibility criteria shown on the page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision label, v3.5.4, was added to the page's revision history, replacing the previous label v3.5.3.SummaryDifference0.1%

- Check47 days agoChange DetectedA site release/revision label displayed on the page footer was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded revision note indicating the current page version (v3.5.0) and removed the previous v3.4.3. This update reflects backend versioning rather than substantive changes to the study details.SummaryDifference0.1%

- Check97 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page. This appears to be a versioning update rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.